Pfizer, AstraZeneca and Moderna have won approval for their Covid vaccines from the UK regulator and the jabs are already being rolled out. But what about the other vaccine candidates and how soon will they come to market?
Our list offers a snapshot of what the vaccine landscape looks like.
The life sciences industry’s response to the pandemic has been unprecedented both in terms of the speed at which it has developed vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human clinical trials.
That’s great news as, in the vaccines business there is often no “one-size-fits-all” solution, with different countries requiring different sorts of vaccines based on a range of variables including climate, land mass and demography. In other words: there is plenty of room in the market for more than one vaccine.
Covid vaccines approved by the UK
Pfizer/BioNtech
UK approval date: December 2, 2020
Doses: 2
Efficacy: 90pc +
Type: mRNA
Doses sold or pre-ordered globally: The total sum is undisclosed, but we know it has 300m on order from the EU and 200m from the US, which, together with the UK, brings the total to 540m
Doses procured by the UK: 40m
Manufacturing capability: Up to 2bn doses this year
